Delivery Order SPE2DB20D1004-SPE2DB24FF1J1

Award Date 12/29/23
Potential Completion Date 1/2/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,036.55, is for the delivery of Jardiance 25 mg tablets. The contract has an ultimate completion date of March 4, 2025 and uses a firm fixed price pricing type. This contract is not designated as a set-aside and is an award under AmerisourceBergen's existing Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,296.78, is for the supply of Jardiance 10 mg tablets. The contract is a Firm Fixed Price, Delivery Order contract type and has an ultimate completion date of March 18, 2025. This appears to be an open competition contract, as it does not have a set-aside designation. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,683.29, is for the supply of Jardiance 25 mg tablets with a completion date of December 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,827.27, is for the supply of Jardiance 25 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of November 16, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,440.98, is for the supply of Jardiance 25 mg tablets. It is a firm fixed-price contract with a period of performance through February 26, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,165.95, is for the delivery of Jardiance 25 mg tablet medication. The award has an ultimate completion date of July 11, 2024 and is a firm fixed-price contract. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,824.35, is for the delivery of Jardiance 25 mg tablets. It is a firm-fixed-price contract with a period of performance through January 31, 2025. This appears to be an open competition contract, as no set-aside designation is mentioned. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,433.69, is for the delivery of Jardiance 10 mg tablets. The contract is a firm-fixed-price delivery order, with an ultimate completion date of September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets (90 count) at a ceiling value of $15,405.72. The contract is a firm-fixed price delivery order with a completion date of July 6, 2022. This contract award is a part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,423.41 and a period of performance through March 27, 2025. It is a firm fixed-price contract for the supply of Jardiance 25 mg tablets. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF1J1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,266.27, is for the delivery of Jardiance 25 mg tablets. The contract has an ultimate completion date of January 2, 2024 and a firm fixed price pricing type. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/13/25, 10:21 AM